During Cancer, Do What Brings You Joy, Vanessa Bayer Says


When going through cancer, former ‘Saturday Night Live’ cast member Vanessa Bayer found comedy. Now, she urges others to find what brings them joy.

When Vanessa Bayer was going through cancer treatments as a teenager, she discovered her love of comedy — something that eventually led her down a career path that included being a cast member of “Saturday Night Live” and starring in multiple comedy movies and television shows.

“Do the things that bring you joy. It’s a really great way to get through (and) to navigate a cancer journey,” Bayer said in an interview with CURE®.

Bayer, who is also an author, was the keynote speaker at CURE®’s 10th Annual MPN Heroes® program in December. In her speech, she discussed how her acute lymphoblastic leukemia diagnosis, which she received when she was 15 years old, shaped her life.

Not only did Bayer discover her love for comedy during her cancer experience, but it also made her determined not to be underestimated; she did not want people to take pity on her or define her by her diagnosis, so she therefore became a self-proclaimed overachiever. “And I think that has a lot to do with where I am today,” she said at her speech during the event.

READ MORE: CURE® Salutes 8 Individuals’ Efforts During 10th Annual MPN Heroes® Program


Do the things that bring you joy. It is really a great way to get through (and) to navigate a cancer journey. And, you know, for me comedy was one of those things. And I think, you know, along those lines, and along kind of the lines of what I was saying in my speech tonight (at the MPN Heroes® Program), I really do tell everyone who is battling cancer, dealing with any kind of trauma, really use it to get like whatever you can get because honestly, what you're going through is so difficult. You deserve whatever sort of perks you can get.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE